Defining Neurovascular Metabolism in Neurodevelopmental and Neuropsychiatric Disorders

  • Post author:
  • Post category:

Research Objective Neuropsychiatric disorders correlate to impaired metabolism, though understudied. We will describe how metabolism impacts disorders etiology and identify new, tractable therapeutic strategies. Impact We will uncover metabolic drivers…

Continue ReadingDefining Neurovascular Metabolism in Neurodevelopmental and Neuropsychiatric Disorders

Multiomic Studies of Idiopathic Intellectual Disability and Autism Spectrum Disorder (ID/ASD)

  • Post author:
  • Post category:

Research Objective We provide mechanistic insight into idiopathic Intellectual Disability (ID) and Autism Spectrum Disorder (ASD) based on aberrant redox-mediated posttranslational modifications related to air pollution Impact How air pollution…

Continue ReadingMultiomic Studies of Idiopathic Intellectual Disability and Autism Spectrum Disorder (ID/ASD)

A Phase I Open Label Study to Evaluate the Safety and Tolerability of ISP-001 in Patients with Mucopolysaccharidosis Type 1

  • Post author:
  • Post category:

Therapeutic Candidate or Device B cells will be isolated from patients suffering MPSI. These will be transformed with a normal copy of the gene and re-introduced into the patient Indication…

Continue ReadingA Phase I Open Label Study to Evaluate the Safety and Tolerability of ISP-001 in Patients with Mucopolysaccharidosis Type 1

Development of a Gene Therapy for the Treatment of WWOX related epileptic encephalopathy (WOREE)

  • Post author:
  • Post category:

Therapeutic Candidate or Device MZ-9138 is an AAV9 gene therapy Indication WWOX-related epileptic encephalopathy Therapeutic Mechanism MZ-9138 delivered to the brain may transduce neurons to create functioning WWOX protein and…

Continue ReadingDevelopment of a Gene Therapy for the Treatment of WWOX related epileptic encephalopathy (WOREE)